Summit Therapeutics Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Summit Therapeutics (US:SMMT) Globenewswire·2026-05-04 21:23SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Summit Therapeutics Inc. (NASDAQ: SMMT). The investigation focuses on Summit’s executive officers and whether investor losses may be recovered under federal securities laws. What if I purchased Summit securities?If you purchased Summit securities and suffered losses on your investment, join our investigation now: Click here to join the investigation. Or for more information, contact J ...